1. Home
  2. PTCT vs POST Comparison

PTCT vs POST Comparison

Compare PTCT & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$71.41

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Post Holdings Inc.

POST

Post Holdings Inc.

HOLD

Current Price

$84.00

Market Cap

5.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
POST
Founded
1998
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.0B
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
PTCT
POST
Price
$71.41
$84.00
Analyst Decision
Buy
Buy
Analyst Count
17
7
Target Price
$80.65
$124.50
AVG Volume (30 Days)
794.0K
1.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
N/A
EPS
0.90
4.59
Revenue
$264,734,000.00
$8,158,100,000.00
Revenue This Year
N/A
$4.93
Revenue Next Year
$17.70
$0.47
P/E Ratio
$79.77
$18.37
Revenue Growth
36.19
2.97
52 Week Low
$57.08
$75.40
52 Week High
$90.87
$116.35

Technical Indicators

Market Signals
Indicator
PTCT
POST
Relative Strength Index (RSI) 45.98 50.42
Support Level $67.57 $76.27
Resistance Level $73.86 $93.96
Average True Range (ATR) 2.00 2.44
MACD 0.17 0.73
Stochastic Oscillator 54.41 73.35

Price Performance

Historical Comparison
PTCT
POST

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

Share on Social Networks: